With the rising prevalence of Autism Spectrum Disorders (ASD), more parents are seeking alternative treatments to address the underlying symptoms of autism. Traditional medications often fall short of producing desired outcomes for many individuals with autism and their families. However, studies have highlighted hyperbaric oxygen therapy (HBOT) as a promising treatment option that parents and physicians are increasingly turning to in order to alleviate the effects of ASD. This non-invasive therapy involves simple one-hour daily sessions, during which the parent and child enter a hyperbaric chamber to receive elevated levels of oxygen. HBOT has been demonstrated to reduce inflammation and enhance cognitive functions, significantly benefiting thousands of individuals with ASD.
Research has indicated the following advantages of HBOT for Autism Spectrum Disorders:
The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.
In 2009, a multi-center, randomized, controlled, double-blind trial was published in BMC Pediatrics, examining the impact of HBOT on 56 children diagnosed with ASD, aged 2-7. The study involved six separate HBOT centers, where 30 children received 40 one-hour sessions over four weeks, while the remaining 26 children underwent sham treatment. Upon completion of the study, significant improvements were noted in the treatment group’s mean physician Clinical Global Impression scores for overall functioning, receptive language, social interaction, and eye contact, with 80 percent demonstrating improvement. Additionally, major improvements were observed in irritability, stereotypy, hyperactivity, and speech, as measured by the Aberrant Behavior Checklist. Furthermore, substantial improvements were noted in sensory/cognitive awareness, as indicated by ratings on the Autism Treatment Evaluation Checklist. Both the treated and sham-treated groups found HBOT to be safe and well tolerated by the children and their parents.
The statements made in this document have not been evaluated or approved by the FDA. All information presented is based on clinical data and not anecdotal evidence.
Learn about purchase and rental programs.
Copyright © 2024 Hyperbaric Hub LLC All Rights Reserved
